Print Page   |   Contact Us   |   Your Cart   |   Report Abuse   |   Sign In   |   Apply for NAQC Membership
Site Search
Sign up for NAQC membership today!

Receive a monthly issue of Connections!
NAQC Newsroom: Tobacco Control

FDA Hearing on NRT and Innovative Tobacco Cessation Treatments Scheduled for December 17

Wednesday, November 28, 2012  
Posted by: Natalia Gromov


FDA will hold a public hearing on December 17, 2012, from 8 a.m. to 5 p.m. in Silver Spring, Maryland on the topic of NRT and innovative tobacco cessation treatments. Anyone who would like to present in-person must register by December 6. A live Web cast of the public hearing will be available and a video recording will also be made available. Highlights of the content of the meeting are provided below and full details are available in the Federal Register Notice.

Topics that will be considered at the public hearing include:

  • Fast-track status for smoking cessation products, including NRTs
  • Extended use of NRTs for treatment of tobacco dependence
  • Additional indications for NRTs such as craving relief and relapse prevention
  • Report to Congress on how best to regulate innovative products and treatments for tobacco cessation, tobacco reduction and reduction in harm from tobacco use
Address of public hearing:
FDA White Oak Campus
10903 New Hampshire Ave
Building 31, Room 1503
Silver Spring, MD 20993

Live Web cast: (recording available at same url)

Submission of comments:
Written: Division of Dockets Management (HFA-305)
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

For additional information:
Ayanna Augustus

Membership 11 years!.

    3219 E. Camelback Road, #416, Phoenix, AZ 85018 | Ph: 800.398.5489 | Fax: 800.398.5489 |